The "will they or won't they" between
Roche (OTC:
RHHBY) and
Illumina (Nasdaq:
ILMN)
has continued to spur rumors and debate ever since Roche walked away
from its bid for the leading gene sequencing company earlier this year.
Rumors in the fall said that Roche was working on yet another bid, while
subsequent rumors claimed that agreements had been reached at $60 per
share or even $66 per share. Given reports of Roche chairman Franz
Humer's statement to a Swiss newspaper on Sunday, however, it looks like
this deal is off once again.
Click here to continue:
http://www.investopedia.com/stock-analysis/2013/Has-Roche-Said-Nein-To-Illuminas-Asking-Price-Once-More-RHHBY-ILMN-PACB-LIFE0107.aspx
No comments:
Post a Comment